See how your answers relate to your colleagues'.

According to the webcast

with Richard Bergenstal, MD; Steven Edelman, MD and Boris Kovatchev, PhD:
The DIaMonD (Multiple Daily Injections and Continuous Glucose
Monitoring in Diabetes) Trial found that
CGM significantly decreased diabetes distress
CGM significantly enhanced hypoglycemic confidence
CGM significantly improved both diabetes distress and hypoglycemic confidence
CGM significantly improved patients' well-being
CGM significantly improved patients' health status

Submit is supported by independent educational grants from Insulet Corporation, Madrigal Pharmaceuticals, MannKind Corporation, Medtronic, Stanford University, and Tandem Diabetes Care, Inc.
©2024 CogniMed Inc. All rights reserved.